Buclizine

Buclizine
Systematic (IUPAC) name
(RS)-1-[(4-chlorophenyl)- phenyl-methyl]-4- [(4-tert-butylphenyl) methyl] piperazine
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
Identifiers
CAS Number 82-95-1 YesY
ATC code R06AE01 (WHO)
PubChem CID 6729
IUPHAR/BPS 7134
DrugBank DB00354 YesY
ChemSpider 6473 YesY
UNII 0C94V6X681 YesY
ChEBI CHEBI:3205 YesY
ChEMBL CHEMBL1201271 N
Chemical data
Formula C28H33ClN2
Molar mass 433.028 g/mol
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Buclizine is an antihistamine and anticholinergic of the piperazine derivative family. It is considered to be an antiemetic, similar to meclizine.[1]

In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare at migraine sufferers.[2]

References

  1. Mostafa, G. A. E.; Al-Badr, A. A. (2011). "Buclizine". Profiles of drug substances, excipients, and related methodology. Profiles of Drug Substances, Excipients and Related Methodology 36: 1–33. doi:10.1016/B978-0-12-387667-6.00001-4. ISBN 9780123876676. PMID 22469258.
  2. Behrendt, W. A.; Cserepes, J. (1985). "Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol ('Migraleve') in tablet and suppository form in rats". Pharmatherapeutica 4 (5): 322–331. PMID 4070325.


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.